226 related articles for article (PubMed ID: 22531756)
1. Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy.
Zhang S; van Sighem A; Kesselring A; Gras L; Smit C; Prins JM; Kauffmann R; Richter C; de Wolf F; Reiss P
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):265-72. PubMed ID: 22531756
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatment.
Zhang S; van Sighem A; Gras L; Reiss P; Smit C; Kroon F; Jurriaans S; Prins J; Lange J; de Wolf F
Antivir Ther; 2010; 15(4):555-62. PubMed ID: 20587848
[TBL] [Abstract][Full Text] [Related]
3. Effect of persistent moderate viremia on disease progression during HIV therapy.
Raffanti SP; Fusco JS; Sherrill BH; Hansen NI; Justice AC; D'Aquila R; Mangialardi WJ; Fusco GP;
J Acquir Immune Defic Syndr; 2004 Sep; 37(1):1147-54. PubMed ID: 15319674
[TBL] [Abstract][Full Text] [Related]
4. CD4+ count-guided interruption of antiretroviral treatment.
; El-Sadr WM; Lundgren J; Neaton JD; Gordin F; Abrams D; Arduino RC; Babiker A; Burman W; Clumeck N; Cohen CJ; Cohn D; Cooper D; Darbyshire J; Emery S; Fätkenheuer G; Gazzard B; Grund B; Hoy J; Klingman K; Losso M; Markowitz N; Neuhaus J; Phillips A; Rappoport C
N Engl J Med; 2006 Nov; 355(22):2283-96. PubMed ID: 17135583
[TBL] [Abstract][Full Text] [Related]
5. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
Deeks SG; Wrin T; Liegler T; Hoh R; Hayden M; Barbour JD; Hellmann NS; Petropoulos CJ; McCune JM; Hellerstein MK; Grant RM
N Engl J Med; 2001 Feb; 344(7):472-80. PubMed ID: 11172188
[TBL] [Abstract][Full Text] [Related]
6. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictive value of intermittent viremia with combination hiv therapy.
Havlir DV; Bassett R; Levitan D; Gilbert P; Tebas P; Collier AC; Hirsch MS; Ignacio C; Condra J; Günthard HF; Richman DD; Wong JK
JAMA; 2001 Jul; 286(2):171-9. PubMed ID: 11448280
[TBL] [Abstract][Full Text] [Related]
8. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
[TBL] [Abstract][Full Text] [Related]
9. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.
Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605
[TBL] [Abstract][Full Text] [Related]
10. CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load.
Miller V; Staszewski S; Sabin C; Carlebach A; Rottmann C; Weidmann E; Rabenau H; Hill A; Lepri AC; Phillips AN
J Infect Dis; 1999 Aug; 180(2):530-3. PubMed ID: 10395876
[TBL] [Abstract][Full Text] [Related]
11. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
12. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
[TBL] [Abstract][Full Text] [Related]
13. Immunologic, virologic, and clinical consequences of episodes of transient viremia during suppressive combination antiretroviral therapy.
van Sighem A; Zhang S; Reiss P; Gras L; van der Ende M; Kroon F; Prins J; de Wolf F
J Acquir Immune Defic Syndr; 2008 May; 48(1):104-8. PubMed ID: 18285709
[TBL] [Abstract][Full Text] [Related]
14. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
Baker JV; Peng G; Rapkin J; Krason D; Reilly C; Cavert WP; Abrams DI; MacArthur RD; Henry K; Neaton JD;
J Acquir Immune Defic Syndr; 2008 Aug; 48(5):541-6. PubMed ID: 18645520
[TBL] [Abstract][Full Text] [Related]
15. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
Brumme ZL; Chan KJ; Dong WW; Mo T; Wynhoven B; Hogg RS; Montaner JS; O'Shaughnessy MV; Harrigan PR
AIDS; 2002 Sep; 16(14):1929-33. PubMed ID: 12351953
[TBL] [Abstract][Full Text] [Related]
16. Initial suboptimal CD4 reconstitution with antiretroviral therapy despite full viral suppression in a cohort of HIV-infected patients in Senegal.
Batista G; Buvé A; Ngom Gueye NF; Manga NM; Diop MN; Ndiaye K; Thiam A; Ly F; Diallo A; Ndour CT; Seydi M
Med Mal Infect; 2015 Jun; 45(6):199-206. PubMed ID: 25907261
[TBL] [Abstract][Full Text] [Related]
17. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
Joya C; Won SH; Schofield C; Lalani T; Maves RC; Kronmann K; Deiss R; Okulicz J; Agan BK; Ganesan A
Clin Infect Dis; 2019 Nov; 69(12):2145-2152. PubMed ID: 30785191
[TBL] [Abstract][Full Text] [Related]
18. Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.
Zhang S; van Sighem A; Kesselring A; Gras L; Prins JM; Hassink E; Kauffmann R; Richter C; de Wolf F; Reiss P;
HIV Med; 2015 May; 16(5):265-72. PubMed ID: 25604160
[TBL] [Abstract][Full Text] [Related]
19. Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy.
Mocroft A; Phillips AN; Ledergerber B; Smith C; Bogner JR; Lacombe K; Wiercinska-Drapalo A; Reiss P; Kirk O; Lundgren JD;
Antivir Ther; 2010; 15(4):563-70. PubMed ID: 20587849
[TBL] [Abstract][Full Text] [Related]
20. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
Mugavero MJ; Napravnik S; Cole SR; Eron JJ; Lau B; Crane HM; Kitahata MM; Willig JH; Moore RD; Deeks SG; Saag MS;
Clin Infect Dis; 2011 Nov; 53(9):927-35. PubMed ID: 21890751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
